These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6842341)

  • 21. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
    del Rosario M; Werlin SL; Lauer SJ
    J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
    Michalak A; Qureshi IA
    Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of glyoxylate and other glycine precursors in the hepatic and renal conjugation of benzoate in normal and hyperammonemic mice.
    Qureshi IA; Clermont P; Letarte J
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1426-30. PubMed ID: 2627683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.
    Shinka T; Inoue Y; Kuhara T; Matsumoto M; Matsumoto I
    Clin Chim Acta; 1985 Oct; 151(3):293-300. PubMed ID: 4053389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
    Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
    Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain uptake of tryptophan in urease-injected hyperammonemic rats after treatment with benzoate or hippurate.
    Bachmann C; Lüthi H; Gradwohl M; Colombo JP
    Biochem Med Metab Biol; 1986 Oct; 36(2):214-9. PubMed ID: 3778687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis.
    Brusilow S; Tinker J; Batshaw ML
    Science; 1980 Feb; 207(4431):659-61. PubMed ID: 6243418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
    Michalak A; Qureshi IA
    Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.
    Kubota K; Ishizaki T
    Eur J Clin Pharmacol; 1993; 45(5):465-8. PubMed ID: 8112377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylsuccinate and mesaconate in urine of patients treated with sodium benzoate.
    Maeda E; Matsuo M; Saiki K; Nakamura H; Matsuo T; Takemine H
    Acta Paediatr Jpn; 1989 Dec; 31(6):721-6. PubMed ID: 2533792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzylamine metabolism at low O2 concentrations. Relative sensitivities of monoamine oxidase, aldehyde dehydrogenase and hippurate synthesis to hypoxia.
    Jones DP
    Biochem Pharmacol; 1984 Feb; 33(3):413-7. PubMed ID: 6704160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis.
    Yamada S; Yamamoto T; Suou T; Fujii T; Takayama M; Amisaki T; Tabuchi F; Kobayashi J; Hasegawa M; Hoshino U
    Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):53-62. PubMed ID: 1518961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.
    Batshaw ML; Brusilow S; Waber L; Blom W; Brubakk AM; Burton BK; Cann HM; Kerr D; Mamunes P; Matalon R; Myerberg D; Schafer IA
    N Engl J Med; 1982 Jun; 306(23):1387-92. PubMed ID: 7078580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hyperammonemia with sodium benzoate.
    Kodama H; Kamoshita S; Motokawa Y
    J Pediatr; 1983 Sep; 103(3):498. PubMed ID: 6886925
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of urea cycle disorders.
    Batshaw ML; Monahan PS
    Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans.
    Kubota K; Ishizaki T
    Eur J Clin Pharmacol; 1991; 41(4):363-8. PubMed ID: 1804654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoate.
    Michalak A; Qureshi IA
    Biochem Mol Med; 1995 Apr; 54(2):96-104. PubMed ID: 8581365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.